Mega Lifesciences Stock

Equities

MEGA

TH4984010009

Pharmaceuticals

End-of-day quote Thailand S.E. 06:00:00 2024-04-22 pm EDT 5-day change 1st Jan Change
41 THB +0.61% Intraday chart for Mega Lifesciences 0.00% +1.86%
Sales 2024 * 16.14B 436M Sales 2025 * 17.03B 460M Capitalization 35.53B 959M
Net income 2024 * 2.44B 65.81M Net income 2025 * 2.64B 71.29M EV / Sales 2024 * 2 x
Net cash position 2024 * 3.26B 88.04M Net cash position 2025 * 3.8B 103M EV / Sales 2025 * 1.86 x
P/E ratio 2024 *
14.4 x
P/E ratio 2025 *
13.4 x
Employees -
Yield 2024 *
4.26%
Yield 2025 *
4.58%
Free-Float 37.92%
More Fundamentals * Assessed data
Dynamic Chart
Transcript : Mega Lifesciences Public Company Limited, 2023 Earnings Call, Feb 23, 2024
Mega Lifesciences Public Company Limited Proposes Dividend for the Year Ended December 31, 2023, Payable on April 22, 2024 CI
Mega Lifesciences Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Transcript : Mega Lifesciences Public Company Limited, Q3 2023 Earnings Call, Nov 14, 2023
Mega Lifesciences Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Mega Lifesciences Public Company Limited Announces Cash Dividend for the Period from January 1, 2023to June 30, 2023, Payable on September 8, 2023 CI
Mega Lifesciences Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Transcript : Mega Lifesciences Public Company Limited, Q1 2023 Earnings Call, May 15, 2023
Mega Lifesciences Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Mega Lifesciences Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Transcript : Mega Lifesciences Public Company Limited, 2022 Earnings Call, Feb 24, 2023
Transcript : Mega Lifesciences Public Company Limited, Q3 2022 Earnings Call, Nov 15, 2022
Mega Lifesciences Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Transcript : Mega Lifesciences Public Company Limited, Q2 2022 Earnings Call, Aug 15, 2022
Mega Lifesciences Public Company Limited Announces Cash Dividend for the Period from January 1, 2022 to June 30, 2022, Payable on September 9, 2022 CI
More news
1 day-1.21%
1 week-0.61%
Current month-2.98%
3 months-4.12%
6 months-7.39%
Current year+1.24%
More quotes
1 week
39.50
Extreme 39.5
41.75
1 month
39.50
Extreme 39.5
43.75
Current year
39.50
Extreme 39.5
44.25
1 year
34.75
Extreme 34.75
46.75
3 years
32.25
Extreme 32.25
56.50
5 years
17.90
Extreme 17.9
56.50
10 years
15.00
Extreme 15
56.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 85-12-31
Director of Finance/CFO 59 96-12-31
Chief Operating Officer - -
Members of the board TitleAgeSince
Director/Board Member 53 21-05-12
Founder 70 81-12-31
Director/Board Member 67 13-01-31
More insiders
Date Price Change Volume
24-04-22 41 +0.61% 440 484
24-04-22 40.75 -1.21% 727,449
24-04-19 41.25 0.00% 1,716,481
24-04-18 41.25 +1.23% 1,486,876

End-of-day quote Thailand S.E., April 21, 2024

More quotes
Mega Lifesciences Public Company Limited is engaged in manufacturing, marketing, selling and distributing quality pharmaceutical, nutraceutical products and Fast-Moving Consumer Goods (FMCG). Its segments include Maxxcare distribution business, Mega We Care branded products business, and original equipment manufacturer (OEM) business. The Maxxcare distribution business markets, sells and distributes various branded prescription pharmaceutical products, OTC and FMCG products. Its services include warehouse management, collections, including assuming the liability for bad debts, and value-added services. Its Mega We Care branded products business develops, manufactures, markets and sells its own brand of nutraceutical products, prescription pharmaceutical products and OTC products. Mega We Care branded products are sold in a total of 35 countries around the world. Its manufacturing facilities in Thailand and Australia accept various production orders from third-party customers.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
40.75 THB
Average target price
50.06 THB
Spread / Average Target
+22.85%
Consensus